Filter Results:
(1,416)
Show Results For
- All HBS Web
(1,416)
- News (359)
- Research (750)
- Events (1)
- Multimedia (59)
- Faculty Publications (490)
Show Results For
- All HBS Web
(1,416)
- News (359)
- Research (750)
- Events (1)
- Multimedia (59)
- Faculty Publications (490)
- 01 Jun 2020
- News
The Network Effect
coronavirus. Kapoor was tested and by the time he received the results nine days later, they confirmed what he already knew: he had COVID-19 (and so did his wife, a physician, and two of his four kids). Kapoor’s testing experience... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
$7.5 billion—but Moderna was still several years away from producing any of its products at commercial scale. For many of the companies now in the hunt for a vaccine, the choice to scrap 2020 business plans and focus on the emerging virus was not self-evident. Even as... View Details
- September 2022
- Case
HPP: Tapping the Netherlands’ Potential
By: Brian Trelstad and Idelès Kaandorp
Stichting Het Potentieel Pakken (HPP) was launched to solve a systemic problem in the Dutch Labor Market: gender inequity that was leading to a large number of women to work part-time in fields that were in desperately short supply of labor, like health care, child... View Details
Keywords: COVID-19 Pandemic; Grants; Scaling And Growth; Nonprofit Organizations; Opportunities; Gender; Income; Employment; Health Care and Treatment; Human Capital; Mission and Purpose; Motivation and Incentives; Growth and Development Strategy; Employment Industry; Health Industry; Education Industry; Consulting Industry; Europe; Netherlands
Trelstad, Brian, and Idelès Kaandorp. "HPP: Tapping the Netherlands’ Potential." Harvard Business School Case 323-024, September 2022.
- 2021
- Working Paper
COVID-19, Government Performance, and Democracy: Survey Experimental Evidence from 12 Countries
By: Michael Becher, Nicholas Longuet Marx, Vincent Pons, Sylvain Brouard, Martial Foucault, Vincenzo Galasso, Eric Kerrouche, Sandra León Alfonso and Daniel Stegmueller
Beyond its immediate impact on public health and the economy, the COVID-19 pandemic has put democracy under stress. While a common view is that people should blame the government rather than the political system for bad crisis management, an opposing view is that... View Details
Keywords: COVID-19 Pandemic; Government Performance; Democracy; Health Pandemics; Government and Politics; Crisis Management; Public Opinion
Becher, Michael, Nicholas Longuet Marx, Vincent Pons, Sylvain Brouard, Martial Foucault, Vincenzo Galasso, Eric Kerrouche, Sandra León Alfonso, and Daniel Stegmueller. "COVID-19, Government Performance, and Democracy: Survey Experimental Evidence from 12 Countries." NBER Working Paper Series, No. 29514, November 2021. (Revise and resubmit requested, The Journal of Politics.)
- June 2024 (Revised August 2024)
- Case
Hospital for Special Surgery: Returning to a New Normal? (A)
By: Robert S. Huckman, Michael Lingzhi Li and Camille Gregory
Early on the morning of April 27, 2020, Justin Oppenheimer stood outside the entrance to the lobby of the Hospital for Special Surgery (HSS) Pavilion Building with mixed emotions. On one hand, Oppenheimer, HSS’ Enterprise Chief Operating Officer and Chief Strategy... View Details
Keywords: Operations Management; Scheduling; Optimization; COVID-19; Health Care and Treatment; Operations; Customer Focus and Relationships; Disruption; Health Industry; United States
Huckman, Robert S., Michael Lingzhi Li, and Camille Gregory. "Hospital for Special Surgery: Returning to a New Normal? (A)." Harvard Business School Case 624-092, June 2024. (Revised August 2024.)
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- Article
The Case for a COVID Vaccine Lottery
By: Scott Duke Kominers and Alex Tabarrok
Even the smartest distribution plans are complicated by a stubborn fact: We won't have enough for everyone right away. View Details
Kominers, Scott Duke, and Alex Tabarrok. "The Case for a COVID Vaccine Lottery." Bloomberg Opinion (November 9, 2020).
- February 24, 2022
- Article
Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC
By: Regina E. Herzlinger and Richard Boxer
During the initial phases of the COVID-19 pandemic, many U.S. hospitals could not provide enough beds to meet demand. Solving the problem of inadequate capacity is of utmost importance in the “new normal,” which requires recognizing the ongoing need for hospital-based... View Details
Keywords: COVID; COVID-19 Pandemic; Hospital Capacity; SEC Regulation; Health Pandemics; Crisis Management; Performance Capacity; Planning
Herzlinger, Regina E., and Richard Boxer. "Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC." Harvard Business School Working Knowledge (February 24, 2022).
- February 2022 (Revised January 2023)
- Case
Huazhu: A Chinese Hotel Giant's Journey of Digital Transformation
By: Feng Zhu, Yulin Fang, Bonnie Yining Cao and Duan Yang
Based in Shanghai, China, Huazhu Group, the world’s third-largest hotel operator, was known for its standardized IT system. It helped the company boost efficiency during the COVID-19 pandemic. Chief Digital Officer Xinxin Liu also faced some longer-term challenges:... View Details
Keywords: Hotel Industry; COVID-19 Pandemic; Labor; Business or Company Management; Emerging Markets; Information Technology; Operations; Strategy; Digital Transformation; Accommodations Industry; China; United States; Singapore; Germany; Hong Kong
Zhu, Feng, Yulin Fang, Bonnie Yining Cao, and Duan Yang. "Huazhu: A Chinese Hotel Giant's Journey of Digital Transformation." Harvard Business School Case 622-071, February 2022. (Revised January 2023.)
- October 2022
- Case
Afrigen Biologics: Vaccines for the Global South
By: Debora L. Spar and Julia Comeau
The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details
Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa
Spar, Debora L., and Julia Comeau. "Afrigen Biologics: Vaccines for the Global South." Harvard Business School Case 323-030, October 2022.
- Oct 2020
- Other Presentation
How to Lead in a Crisis
By: Amy C. Edmondson
Humility, transparency and urgency are the keys to successfully steering an organization—big or small—through the challenges that come your way. Leadership expert Amy C. Edmondson provides clear advice and examples to help any leader rise to the occasion. View Details
Edmondson, Amy C. "How to Lead in a Crisis." In The Way We Work Series. TED Talks, October 2020.
- 01 Jun 2020
- News
Vital Signs
Halle Tecco (MBA 2011) Halle Tecco (MBA 2011) Halle Tecco (MBA 2011) has been a health care investor since she graduated from HBS. Her fascination with the massive disruptions underway in the industry led her to found the Rock Health venture fund in 2010, and today... View Details
- August 29, 2022
- Other Article
Income Inequality Is Rising. Are We Even Measuring It Correctly?
By: Jon M. Jachimowicz, K. Blesch and Oliver P. Hauser
Income inequality is on the rise in many countries around the world, according to the United Nations. What’s more, disparities in global income were exacerbated by the COVID-19 pandemic, with some countries facing greater economic losses than others.
Policymakers... View Details
Keywords: Income Inequality; Gini Coefficient; COVID-19 Pandemic; Government Administration; Equality and Inequality; Health Pandemics; Measurement and Metrics
Jachimowicz, Jon M., K. Blesch, and Oliver P. Hauser. "Income Inequality Is Rising. Are We Even Measuring It Correctly?" Harvard Business School Working Knowledge (August 29, 2022).
- March 2021 (Revised November 2022)
- Case
Blue Meridian Partners (A): Scaling for Impact
In 2018, Edna McConnell Clark Foundation in a bold move transferred all its assets to a fund pooled with other General Partners and Limited Partners, called Blue Meridian Partners, to focus substantial long range investments in a few carefully chosen nonprofits.The... View Details
Keywords: Venture Philanthropy; Scaling; COVID-19 Pandemic; Social Justice; Philanthropy and Charitable Giving; Venture Capital; Business Model; Social Issues; Poverty; Values and Beliefs; Decisions; Corporate Social Responsibility and Impact; Nonprofit Organizations; Investment Portfolio
Rangan, V. Kasturi. "Blue Meridian Partners (A): Scaling for Impact." Harvard Business School Case 521-090, March 2021. (Revised November 2022.)
- Article
The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in U.S. Health Care Markets
By: Leemore S. Dafny
This article describes potential regulatory and legislative reforms to assist antitrust enforcement agencies in halting anticompetitive acquisitions and practices, and preserving and promoting competition in health care markets. View Details
Keywords: Health Care and Treatment; Markets; Competition; Governing Rules, Regulations, and Reforms
Dafny, Leemore S. "The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in U.S. Health Care Markets." Promarket (June 10, 2021).
- Article
Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]
By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
mRNA technology has just helped to develop vaccines against COVID-19. Now, like Apple's iOS, it could provide the basis for new innovation platforms. View Details
Keywords: mRNA; COVID-19; Vaccines; Health Care and Treatment; Health Pandemics; Innovation and Invention; Health Industry
Stern, Ariel Dora, Timo Minssen, W. Nicholson Price, II, and Christoph Grimpe. "Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]." Harvard Business Manager (July 2022).
- May 21, 2020
- Editorial
Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?
By: Leemore S. Dafny and J. Michael McWilliams
Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details
Keywords: COVID-19; Primary Care; Health Pandemics; Health Care and Treatment; Financial Condition; Insurance
Dafny, Leemore S., and J. Michael McWilliams. "Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?" Health Affairs Blog (May 21, 2020).
- Article
How to End the Plasma Shortage for Coronavirus Patients
Those who have recovered from the virus will donate more blood if given the right incentives. View Details
Keywords: COVID-19; Convalescent Plasma; Health Pandemics; Health Care and Treatment; Market Design; Strategy
Kominers, Scott Duke. "How to End the Plasma Shortage for Coronavirus Patients." Bloomberg Opinion (May 11, 2020).